The latest market price and reference cost of each tube of Lurbinectedin

Lurbinectedin (Lurbinectedin) is an anti-tumor drug used to treat small cell lung cancer (SCLC). It has not yet been officially launched in mainland China, so domestic patients cannot purchase it directly through hospitals or pharmacies. Patients who need the drug often need to obtain it through overseas channels, which also brings drug price and accessibility into focus.

In overseas markets, the price of the original drug Rubicatin is relatively high. For example, the US version sells for about more than 90,000 yuan per box, while the Singapore version costs about more than 30,000 yuan. In the Hong Kong market, 4mg Rubicatin is priced at more than 20,000 yuan. Due to the influence of exchange rates and market supply and demand factors, selling prices in different regions may fluctuate to a certain extent, which means that patients need to fully understand the price information when purchasing.

At present, there are no generic drugs of Rubicatin on the overseas market, so all drugs available for purchase are original versions. Compared with the high price of original drugs, some patients may consider importing original drugs through formal channels to ensure drug quality and efficacy. It is worth noting that when purchasing overseas, you need to pay attention to transportation and tariff issues, and at the same time, you must comply with the medication regulations of the country or region where you are located.

Overall, although Rubicatin cannot be purchased directly in China, it has important clinical value in the treatment of small cell lung cancer. When considering using this drug, patients should consult professional medical institutions to learn about the latest market prices, overseas purchase channels and relevant regulations to ensure safe and legal access to the drug, and to develop a reasonable treatment plan based on the guidance of a doctor.

Reference link:https://www.drugs.com